Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldblatt

Showing results (161-170 of 242) with videos related to

Pageof 25
Sort By:
The Lancet. Haematology|July 5, 2021
Antibody responses after SARS-CoV-2 vaccination in patients with lymphomaSean H Lim, Nicola Campbell, Marina Johnson, et al.
Vaccine|March 19, 2019
Comparison between a new multiplex electrochemiluminescence assay and the WHO reference enzyme-linked immunosorbent assay to measure serum antibodies against pneumococcal serotype-specific polysaccharidesMuriel Feyssaguet, Aurélie Bellanger, Florence Nozay, et al.
Plos One|February 1, 2013
Pediatric invasive pneumococcal disease caused by vaccine serotypes following the introduction of conjugate vaccination in DenmarkZitta B Harboe, Palle Valentiner-Branth, Helene Ingels, et al.
Mbio|March 12, 2020
Vaccine-Induced Th1-Type Response Protects against Invasive Group A <i>Streptococcus</i> Infection in the Absence of Opsonizing AntibodiesTania Rivera-Hernandez, Mira Syahira Rhyme, Amanda J Cork, et al.
Archives of Disease in Childhood|October 14, 2011
Emotional and behavioural difficulties in chronic granulomatous diseaseTheresa S Cole, Laura K R Jones, Paraic McGrogan, et al.
Infection and Immunity|December 12, 2018
A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal <i>Streptococcus pneumoniae</i> ChallengeWin-Yan Chan, Claire Entwisle, Giuseppe Ercoli, et al.
Plos Pathogens|March 9, 2017
Correction: Naturally Acquired Human Immunity to Pneumococcus Is Dependent on Antibody to Protein AntigensRobert Wilson, Jonathan M Cohen, Mark Reglinski, et al.
Plos Pathogens|January 31, 2017
Naturally Acquired Human Immunity to Pneumococcus Is Dependent on Antibody to Protein AntigensRobert Wilson, Jonathan M Cohen, Mark Reglinski, et al.
Vaccine|July 2, 2022
Methodology for a correlate of protection for group B Streptococcus: Report from the Bill & Melinda Gates Foundation workshop held on 10 and 11 February 2021Peter B Gilbert, Richard Isbrucker, Nick Andrews, et al.
Nature Communications|January 9, 2024
Genomic and panproteomic analysis of the development of infant immune responses to antigenically-diverse pneumococciNicholas J Croucher, Joseph J Campo, Timothy Q Le, et al.
Pageof 25

Showing results (161-170 of 242) with videos related to

Sort By:
Pageof 25
The Lancet. Haematology|July 5, 2021
Antibody responses after SARS-CoV-2 vaccination in patients with lymphomaSean H Lim, Nicola Campbell, Marina Johnson, et al.
Vaccine|March 19, 2019
Comparison between a new multiplex electrochemiluminescence assay and the WHO reference enzyme-linked immunosorbent assay to measure serum antibodies against pneumococcal serotype-specific polysaccharidesMuriel Feyssaguet, Aurélie Bellanger, Florence Nozay, et al.
Plos One|February 1, 2013
Pediatric invasive pneumococcal disease caused by vaccine serotypes following the introduction of conjugate vaccination in DenmarkZitta B Harboe, Palle Valentiner-Branth, Helene Ingels, et al.
Mbio|March 12, 2020
Vaccine-Induced Th1-Type Response Protects against Invasive Group A <i>Streptococcus</i> Infection in the Absence of Opsonizing AntibodiesTania Rivera-Hernandez, Mira Syahira Rhyme, Amanda J Cork, et al.
Archives of Disease in Childhood|October 14, 2011
Emotional and behavioural difficulties in chronic granulomatous diseaseTheresa S Cole, Laura K R Jones, Paraic McGrogan, et al.
Infection and Immunity|December 12, 2018
A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal <i>Streptococcus pneumoniae</i> ChallengeWin-Yan Chan, Claire Entwisle, Giuseppe Ercoli, et al.
Plos Pathogens|March 9, 2017
Correction: Naturally Acquired Human Immunity to Pneumococcus Is Dependent on Antibody to Protein AntigensRobert Wilson, Jonathan M Cohen, Mark Reglinski, et al.
Plos Pathogens|January 31, 2017
Naturally Acquired Human Immunity to Pneumococcus Is Dependent on Antibody to Protein AntigensRobert Wilson, Jonathan M Cohen, Mark Reglinski, et al.
Vaccine|July 2, 2022
Methodology for a correlate of protection for group B Streptococcus: Report from the Bill & Melinda Gates Foundation workshop held on 10 and 11 February 2021Peter B Gilbert, Richard Isbrucker, Nick Andrews, et al.
Nature Communications|January 9, 2024
Genomic and panproteomic analysis of the development of infant immune responses to antigenically-diverse pneumococciNicholas J Croucher, Joseph J Campo, Timothy Q Le, et al.
Pageof 25